Fundraising FoxFirst Biotherapeutics
Yongin-si, KR · 4 known investors
Find your way into First Biotherapeutics
Sign up to see every warm intro you have to First Biotherapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the First Biotherapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
1STBIO (퍼스트바이오) is a biotechnology company developing drug programs, including the HPK1 inhibitor immuno-oncology candidate FB849 and the NLY02 program. It focuses on advancing therapeutic pipelines to bring treatments to patients.
Investors · 4
Frequently asked questions
- What does First Biotherapeutics do?
- 1STBIO (퍼스트바이오) is a biotechnology company developing drug programs, including the HPK1 inhibitor immuno-oncology candidate FB849 and the NLY02 program. It focuses on advancing therapeutic pipelines to bring treatments to patients.
- Who are First Biotherapeutics's investors?
- First Biotherapeutics's investors include AF WPartners, Groom Investment, Hyundai Venture Investment Corporation, Solidus Investment.
- Where is First Biotherapeutics headquartered?
- First Biotherapeutics is headquartered in Yongin-si, KR.